Approaching disturbed sleep in late Parkinson's disease: First step toward a proposal for a revised UPDRS

Parkinsonism and Related Disorders

Volumn 8, Issue 2, 2001, Pages 123-131

  Askenasy, J J M ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b NONE   (Israel)

Author keywords

Excessive daytime sleepiness; Light fragmented sleep; REM behavior disorders; Restless legs periodic leg movements during sleep; Sleep attacks; Sleep arousal disturbances; Sleep related breathing disorders; Sleep related hallucinations; Sleep related psychotic behavior

Indexed keywords

APOMORPHINE; BENZODIAZEPINE; CARBIDOPA PLUS LEVODOPA; CHOLINERGIC RECEPTOR; CISAPRIDE; CLONAZEPAM; CLOZAPINE; DESMOPRESSIN; DOMPERIDONE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; NORTRIPTYLINE; OLANZAPINE; OPIATE; RISPERIDONE; TOLCAPONE;

ACTIMETRY; ANAMNESIS; BREATHING DISORDER; CONFERENCE PAPER; DAILY LIFE ACTIVITY; DEPRESSION; DOPAMINERGIC ACTIVITY; DRUG EFFECT; INVOLUNTARY MOVEMENT; MOTOR PERFORMANCE; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; REM SLEEP; RESTLESS LEGS SYNDROME; SLEEP DISORDER; SOMNOLENCE; STRIATONIGRAL DEGENERATION; WEIGHT REDUCTION;

ANTIPARKINSON AGENTS; DOPAMINE AGENTS; HUMANS; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS;

EID: 0034899260     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(01)00026-8     Document Type: Conference Paper

References (91)

1. Sleep dysfunction in Parkinson's disease
2. Sleep disorder related to Parkinson's disease
3. Sleep disturbances on Parkinson's disease patients and spouses
4. A review of health-related quality-of-life concepts and measures for Parkinson's disease
5. An introduction to the concept of 'quality of life in Parkinson's disease'
6. Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease
7. An algorithm for the management of Parkinson's disease
8. Changes in nocturnal sleep in Huntington's and Parkinson's disease
9. A clinical, pharmacologic, and polysomnographic study of sleep benefit in Parkinson's disease
10. Excessive daytime sleepiness and sleep benefit in Parkinson's disease: A community-based study
11. Sleep benefit in Parkinson's disease
12. 'Sleep benefit' in Parkinson's disease
13. Sleep benefit in Parkinson's disease
14. Clinical correlates of sleep benefit in Parkinson's disease
15. The on/off effect in Parkinson's disease treated with levodopa with remarks concerning the effect of sleep
16. Sleep disorders and sleep effect in Parkinson's disease
17. Reversal of sleep disturbance in Parkinson's disease by antiparkinsonian therapy: A preliminary study
18. Sleep Disoders in Parkinson's disease
19. Controlled release levodopa in Parkinson's disease: Influence on selection criteria and conversion recommendations in the clinical outcome of 450 patients
20. Tolcapone: A novel approach to Parkinson's disease
21. Gastrointestinal dysfunction in Parkinson's disease
22. Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring
23. Physical fitness: Benefits of exercise for the older patient
24. Parkinson's disease nurse specialists: An important role in disease management
25. Sleep patterns in extrapyramidal disorders
26. A community-based study of sleep disorders in patients with Parkinson's disease
27. Respiration and sleep in Parkinson's disease
28. Respiration and sleep in Parkinson's disease
29. Sleep-wake complaints in Parkinson's disease
30. The effect of sleep on the dyskinetic movements of Parkinson's disease, Gilles de la Tourette syndrome, Huntington's disease and torsion dystonia
31. Sleep disorders and Parkinson's disease: Study of series
32. Screaming during sleep in Parkinson's disease
33. Sleep movements and associated autonomic nervous activities in patients with Parkinson's disease
34. Treatment of insomnia by concomitent therapy with Zopiclon and Aniracetam in patients with cerebral infarction, cerebroatrophy, Alzheimer's disease and Parkinson's disease
35. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease
36. Effect of low and high frequency thalamic stimulation on sleep of patients with Parkinson's disease and essential tremor
37. Outcome of unilateral and bilateral pallidotomy for Parkinson's disease: Patient assessment
38. Unilateral pallidotomy for reduction of parkinsonian pain
39. Familial fatal Parkinsonism with alveolar hypoventilation and mental depression
40. Dominantly inherited apathy, central hypoventilation, and Parkinson's syndrome: Clinical, biochemical, and neuropathologic studies of 2 new cases
41. Brain-derived neurotrophic factor is required for normal development of the central respiratory rhythm in mice
42. New insights into the ontogeny of breathing from genetically engineered mice
43. Are periodic movements in sleep a basal ganglia dysfunction?
44. Restless leg syndrome and periodics movements of sleep: Physiopathology and treatment with L-dopa
45. Restless leg syndrome and Parkinson's disease: Insights into pathophysiology
46. Restless legs and periodic leg movements in sleep syndromes
47. Correlation of sleep patterns with muscle activity in patients with Parkinson's disease
48. Parkinsonian tremor loses its alternating aspect during non-REM sleep and is inhibited by REM sleep
49. Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome
50. Motor disorders in sleep
51. Different laws govern motor activity in sleep than in wakefulness
52. Is monoaminoxidase inhibitor induced myoclonus serotoninergically mediated?
53. Subcutaneous apomorphine treatment of Parkinson's disease
54. Rapid eye movements sleep behavior disorder: Demographic, clinical and laboratory findings in 93 cases
55. Polysomnographic, neurologic, psychiatric, and clinical outcome report on 70 consecutive cases with REM sleep behavior disorder (RBD): Sustained clonazepam efficacy in 89,5 of 57 cases
56. Parkinson's disease patients with and without REM behavior disorder (RBD): A polysomnographic and clinical comparison
57. REM sleep behavior disorder and Parkinson's disease
58. Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease
59. REM sleep behavior disorder and degenerative dementia: An association likely reflecting Lewy body disease
60. Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa
61. Juvenile Parkinson's disease with REM sleep behavior disorder, sleepiness and daytime REM onset
62. REM sleep behavior disorders in multiple system atrophy
63. Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
64. Complex visual hallucinations. Clinical and neurobiological insights
65. Visual hallucinations associated with Parkinson's disease
66. Levodopa-induced psychosis: A kindling phenomena
67. Hallucinations, sleep fragmentation, and altered drem phenomena in Parkinson's disease
68. Polysmnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations
69. Clozapine in the treatment of psychosis in Parkinson's disease
70. Management of psychotic aspects of Parkinson's disease
71. Behavioral dysfunction in Parkinson's disease
72. Therapy of behavioral disorders in Parkinson's disease
73. Psychotic symptoms in Parkinson's disease
74. Behavioural problems associated with dementia: The role of newer antipsychotics
75. Sleep disorders, pain, and depression in Parkinson's disease
76. An estimate of the incidence of depression in idiopathic Parkinson's disease
77. Sleep in Parkinson's disease. The role of depression and anxiety
78. Sleep deprivation therapy in depressive I illness and Parkinson's disease
79. Depression: Impact and management by the patient and family
80. Treatment of behavioural disturbances in Parkinson's disease
81. Clozapine use in Parkinson's disease: A retrospective analysis in a large multicentered clinical experience
82. Clozapine as a treatment for psychosis in Parkinson's disease: A review
83. Falling asleep at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropinirole
84. Sleep attacks (sleep episodes) with pergolide
85. Sleep attacks and Parkinson's disease treatment
86. Suppression of REM rebound by pergolide
87. Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease
88. Daytime sleepiness in Parkinson's disease
89. Disorders of excessive daytime sleepiness - An update